Clinical trial for Corneal Transplantation
Official title Timing of Glaucoma Drainage Device With Boston Keratoprosthesis
ClinicalTrials.gov ID: NCT02084745
What this study is testing
- What it's testing
- The study compares two timing options for adding a glaucoma drainage device (GDD) to see which better prevents glaucoma progression and preserves vision after a Boston keratoprosthesis (KPro) surgery.
- Who it's for
- Adults who need a Boston keratoprosthesis and are at risk for glaucoma.
- What's involved
- Participants will have either a GDD placed during the KPro surgery or after 6 months. They will visit the eye doctor at several times for eye exams and tests of vision and eye pressure.
- Time commitment
- The study lasts 12 months after the KPro surgery, with visits on day 1, week 1, month 1, 3, 6, and 12; those who get the GDD later have extra visits at day 1, week 1, and month 1 after that surgery.
- Time commitment: about 4 years
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Candidate for corneal transplantation due to loss of corneal clarity
- Verifiable history of one or more previous full thickness donor corneal transplantation failure
- Pre-operative visual acuity of ≤20/80 or worse in the surgical eye
- Age ≥18 years
- Physical condition suitable for undergoing surgery
You likely can't join if
- Terminal glaucoma
- Terminal retinal diseases
The study team makes the final eligibility decision.
Where it is enrolling
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 4 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.